BeOne Medicines Ltd. (ONC)
NASDAQ: ONC
· Real-Time Price · USD
321.57
11.88 (3.84%)
At close: Aug 15, 2025, 3:59 PM
321.00
-0.18%
After-hours: Aug 15, 2025, 07:27 PM EDT
BeOne Medicines Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.76B | 2.52B | 2.63B | 2.7B | 2.59B | 2.79B | 3.17B | 3.07B | 3.41B | 3.54B | 3.87B | 4.2B | 4.53B | 4.35B | 4.38B | 1.38B | 1.78B | 1.9B |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 2.6M | 106.99M | 105.69M | 294.06M | 665.25M | 872M | 1.17B | 1.9B | 2.24B | 2.53B | 2.61B | 2.91B |
Long-Term Investments | 119.47M | 121.14M | 128.93M | 138.23M | 139.77M | 143.62M | 89.64M | 89.28M | 95.61M | 97.95M | 91.78M | 96.08M | 87.59M | 83.89M | 100.79M | 87.43M | 53.95M | 55.71M |
Other Long-Term Assets | 37.4M | 13.08M | 13.38M | 14.2M | 56.95M | 8.77M | 35.72M | 8.95M | 1.51M | 61.11M | -186.46M | 9.93M | 164.78M | 203.01M | 30.65M | 35.25M | 40.77M | 32.05M |
Receivables | 880.13M | 745.98M | 709.11M | 603.01M | 529.45M | 435.29M | 358.03M | 354.62M | 338.14M | 332.16M | 198.98M | 202.65M | 192.28M | 216.35M | 500.18M | 129.58M | 73.79M | 84.01M |
Inventory | 502.87M | 494.66M | 494.99M | 431.68M | 443.26M | 447.35M | 416.12M | 316.93M | 321.33M | 297M | 282.35M | 290.91M | 262.21M | 245.63M | 242.63M | 150.98M | 117.59M | 72.97M |
Other Current Assets | 36.27M | 32.37M | 25.19M | 30.77M | 198.32M | 148.93M | 166.61M | 154.07M | 169.35M | 141.47M | 133.66M | 110.11M | 121.34M | 135.75M | 128.71M | 125.6M | 140.3M | 107.71M |
Total Current Assets | 4.31B | 3.9B | 3.99B | 3.91B | 3.84B | 3.91B | 4.2B | 4.05B | 4.4B | 4.7B | 4.71B | 5.75B | 6.35B | 6.95B | 7.61B | 4.43B | 4.8B | 5.14B |
Property-Plant & Equipment | 1.77B | 1.76B | 1.66B | 1.71B | 1.62B | 1.55B | 1.42B | 1.29B | 1.14B | 1.05B | 845.95M | 829.88M | 633.1M | 624.67M | 686.74M | 609.77M | 538.49M | 509.13M |
Goodwill & Intangibles | 64.89M | 50.14M | 129.76M | 53.94M | 53.72M | 55.17M | 57.14M | 53.66M | 47M | 39.84M | 94.68M | 40.96M | 43.43M | 45.92M | 103.46M | 14.21M | 12.12M | 4.92M |
Total Long-Term Assets | 1.99B | 1.95B | 1.93B | 1.92B | 1.87B | 1.76B | 1.6B | 1.47B | 1.33B | 1.25B | 845.95M | 976.85M | 1.03B | 1.07B | 1.03B | 853.5M | 725.08M | 680.02M |
Total Assets | 6.3B | 5.84B | 5.92B | 5.83B | 5.71B | 5.67B | 5.81B | 5.52B | 5.73B | 5.96B | 6.38B | 6.73B | 7.38B | 8.02B | 8.65B | 5.29B | 5.52B | 5.82B |
Account Payables | 360.78M | 364.5M | 405M | 307.53M | 333.02M | 356.57M | 315.11M | 341.86M | 266.98M | 241.36M | 294.78M | 252.07M | 234.35M | 236.91M | 168.04M | 206.2M | 168.83M | 146.92M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 596.76M | 716.68M | 525.98M | 159.03M | 185.48M | 255.89M | 144.98M | 330.97M | 368.03M | 407.7M | 72.63M | 63.6M | 71.65M |
Short-Term Debt | 808.39M | 763.47M | 851.53M | 863.8M | 851.66M | 826.97M | 688.37M | 328.56M | 421.05M | 281.81M | 328.97M | 441.27M | 380.73M | 407.39M | 427.56M | 442.37M | 434.8M | 405.05M |
Other Current Liabilities | 342.24M | 243.38M | 359.5M | 315.92M | 177.18M | 196.82M | 195.97M | 147.03M | 318.64M | 327.51M | -109.87M | 228.17M | 257.85M | 302.86M | 353.34M | 188.1M | 186.61M | 182.09M |
Total Current Liabilities | 2.21B | 1.98B | 2.21B | 2.03B | 1.94B | 1.88B | 1.81B | 1.28B | 1.41B | 1.25B | 1.02B | 1.41B | 1.4B | 1.38B | 1.6B | 1.3B | 1.24B | 1.11B |
Long-Term Debt | 146.09M | 160.16M | 166.48M | 187.51M | 185.27M | 199.03M | 197.62M | 202.49M | 207.43M | 206.3M | 209.15M | 208.06M | 185.21M | 201.6M | 202.11M | 200.91M | 194.86M | 193.02M |
Other Long-Term Liabilities | 44.39M | 70.3M | 90.7M | 101.12M | 186.49M | 208.88M | 237.97M | 250.38M | 291.82M | 215.09M | 734.25M | 414.57M | 450.13M | 517.99M | 558.25M | 386.31M | 446M | 485.29M |
Total Long-Term Liabilities | 318.08M | 358.29M | 373.79M | 369.45M | 407.16M | 425.63M | 457.83M | 478.35M | 525.07M | 544.92M | 977.91M | 659.53M | 677.25M | 759.58M | 803.41M | 624.83M | 675.03M | 704.88M |
Total Liabilities | 2.53B | 2.34B | 2.59B | 2.39B | 2.35B | 2.31B | 2.27B | 1.76B | 1.93B | 1.8B | 2B | 2.07B | 2.08B | 2.14B | 2.4B | 1.93B | 1.92B | 1.82B |
Total Debt | 1.03B | 996.83M | 1.08B | 1.1B | 1.09B | 1.06B | 930.18M | 579.77M | 677.81M | 545.19M | 891.13M | 710.58M | 632.64M | 671.88M | 694.64M | 699.53M | 680.38M | 638.62M |
Common Stock | 143K | 140K | 138K | 138K | 137K | 136K | 135K | 135K | 137K | 136K | 135K | 135K | 134K | 133K | 133K | 121K | 120K | 119K |
Retained Earnings | -8.51B | -8.61B | -8.61B | -8.45B | -8.33B | -8.21B | -7.96B | -7.59B | -7.81B | -7.43B | -7.08B | -6.64B | -5.97B | -5.4B | -4.97B | -4.38B | -3.97B | -3.49B |
Comprehensive Income | -113.7M | -142.32M | -148.99M | -83.53M | -140.47M | -131.64M | -99.45M | -144.93M | -143.69M | -59.01M | -77.42M | -161.52M | -82.45M | 17.45M | 17.95M | 12.58M | 12.1M | 3.2M |
Shareholders Equity | 3.77B | 3.5B | 3.33B | 3.44B | 3.37B | 3.36B | 3.54B | 3.76B | 3.8B | 4.16B | 4.38B | 4.66B | 5.3B | 5.89B | 6.24B | 3.36B | 3.61B | 4B |
Total Investments | 119.47M | 121.14M | 128.93M | 138.23M | 139.77M | 143.62M | 92.24M | 196.27M | 201.3M | 392M | 757.03M | 968.08M | 1.26B | 1.98B | 2.34B | 2.62B | 2.66B | 2.97B |